WNT5A-mediated ß-catenin-independent signalling is a novel regulator of cancer cell metabolism

Carcinogenesis

Volumn 35, Issue 4, 2014, Pages 784-794

  Sherwood, Victoria ^b   Chaurasiya, Shivendra Kumar ^e   Ekström, Elin J ^a   Guilmain, William ^a   Liu, Qing ^a   Koeck, Tomas ^a   Brown, Kate ^b   Hansson, Karin ^a   Agnarsdóttir, Margrét ^c   Bergqvist, Michael ^d   Jirstróm, Karin ^a   Ponten, Fredrik ^c   James, Peter ^a   Andersson, Tommy ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e DR H S GOUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LACTATE DEHYDROGENASE; PROTEIN KINASE B; WNT5A PROTEIN; ONCOPROTEIN; WNT PROTEIN; WNT5A PROTEIN, HUMAN;

ARTICLE; BIOENERGY; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL ADHESION ASSAY; CELL ENERGY; CELL METABOLISM; CELL MIGRATION; CELL MIGRATION ASSAY; CELL MOTILITY; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA CELL; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; NUCLEAR REPROGRAMMING; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TIME LAPSE IMAGING; WNT SIGNALING PATHWAY; MASS SPECTROMETRY; MELANOMA; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BETA CATENIN; CELL LINE, TUMOR; GLYCOLYSIS; HUMANS; L-LACTATE DEHYDROGENASE; MASS SPECTROMETRY; MELANOMA; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84898645562     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt390     Document Type: Article

References (60)

1. Nusse, R. et al. (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 31, 99-109.
2. Papkoff, J. et al. (1996) Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell. Biol., 16, 2128-2134.
3. McDonald, S.L. et al. (2009) The opposing roles of Wnt-5a in cancer. Br. J. Cancer, 101, 209-214.
4. Dejmek, J. et al. (2005) Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clin. Cancer Res., 11(2 Pt 1), 520-528.
5. Leris, A.C. et al. (2005) WNT5A expression in human breast cancer. Anticancer Res., 25(2A), 731-734.
6. Da Forno, P.D. et al. (2008) WNT5A expression increases during melanoma progression and correlates with outcome. Clin. Cancer Res., 14, 5825-5832.
7. Hanahan, D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
8. Vander Heiden, M.G. et al. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324, 1029-1033.
9. Warburg, O. (1956) On the origin of cancer cells. Science, 123, 309-314.
10. Porporato, P.E. et al. (2011) Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front. Pharmacol., 2, 49.
11. Sethi, J.K. et al. (2010) Wnt signalling and the control of cellular metabolism. Biochem. J., 427, 1-17.
12. Cadoret, A. et al. (2002) New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene, 21, 8293-8301.
13. Schwartz, D.R. et al. (2003) Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res., 63, 2913-2922.
14. Mori, H. et al. (2012) Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J. Clin. Invest., 122, 2405-2416.
15. Yoon, J.C. et al. (2010) Wnt signaling regulates mitochondrial physiology and insulin sensitivity. Genes Dev., 24, 1507-1518.
16. Lens, M.B. et al. (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br. J. Dermatol., 150, 179-185.
17. Hodi, F.S. et al. (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med., 363, 711-723.
18. Chapman, P.B. et al.; BRIM-3 Study Group. (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med., 364, 2507-2516.
19. Robert, C. et al. (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N. Engl. J. Med., 364, 2517-2526.
20. Weeraratna, A.T. et al. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell, 1, 279-288.
21. Jenei, V. et al. (2009) A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc. Natl Acad. Sci. USA, 106, 19473-19478.
22. Lai, S.S. et al. (2012) Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE. Cancer Genet., 205, 552-562.
23. O'Connell, M.P. et al. (2010) The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene, 29, 34-44.
24. Grossmann, A.H. et al. (2013) The small GTPase ARF6 stimulates ß-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Sci. Signal., 6, ra14.
25. Ekström, E.J. et al. (2011) Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion. PLoS ONE, 6, e18674.
26. Jönsson, M. et al. (2002) Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res., 62, 409-416.
27. Strömberg, S. et al. (2009) Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma. J. Proteome Res., 8, 1639-1646.
28. O'Connell, M.P. et al. (2009) Wnt5A activates the calpain-mediated cleavage of filamin A. J. Invest. Dermatol., 129, 1782-1789.
29. Helmlinger, G. et al. (2002) Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin. Cancer Res., 8, 1284-1291.
30. Markert, C.L. et al. (1975) Evolution of a gene. Multiple genes for LDH isozymes provide a model of the evolution of gene structure, function and regulation. Science, 189, 102-114.
31. Quistorff, B. et al. (2011) The isoenzyme pattern of LDH does not play a physiological role; except perhaps during fast transitions in energy metabolism. Aging (Albany. NY)., 3, 457-460.
32. Zhuang, L. et al. (2010) Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Mod. Pathol., 23, 45-53.
33. Balch, C.M. et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol., 27, 6199-6206.
34. Säfholm, A. et al. (2008) The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clin. Cancer Res., 14, 6556-6563.
35. Brand, M.D. et al. (2011) Assessing mitochondrial dysfunction in cells. Biochem. J., 435, 297-312.
36. Camilli, T.C. et al. (2011) Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Pigment Cell Melanoma Res., 24, 175-186.
37. Witze, E.S. et al. (2008) Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science, 320, 365-369.
38. O'Connell, M.P. et al. (2008) Assaying Wnt5A-mediated invasion in melanoma cells. Methods Mol. Biol., 468, 243-253.
39. Beckner, M.E. et al. (1990) Glycolysis as primary energy source in tumor cell chemotaxis. J. Natl Cancer Inst., 82, 1836-1840.
40. Manola, J. et al. (2000) Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J. Clin. Oncol., 18, 3782-3793.
41. Finck, S.J. et al. (1983) LDH and melanoma. Cancer, 51, 840-843.
42. Ho, J. et al. (2012) Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol. Cancer, 11, 76.
43. Gordan, J.D. et al. (2007) HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell, 12, 108-113.
44. Robey, R.B. et al. (2009) Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin. Cancer Biol., 19, 25-31.
45. Kawasaki, A. et al. (2007) Wnt5a promotes adhesion of human dermal fibroblasts by triggering a phosphatidylinositol-3 kinase/Akt signal. Cell. Signal., 19, 2498-2506.
46. Kim, S.Y. et al. (2011) Wnt5a potentiates U46619-induced platelet aggregation via the PI3K/Akt pathway. Mol. Cells, 32, 333-336.
47. Reiter, A.K. et al. (2004) The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver. Int. J. Biochem. Cell Biol., 36, 2169-2179.
48. Thoreen, C.C. et al. (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature, 485, 109-113.
49. Liu, J. et al. (2013) PI3K/Akt-dependent phosphorylation of GSK3ß and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration. Cell. Signal., 25, 447-456.
50. Ainscow, E.K. et al. (1999) Top-down control analysis of ATP turnover, glycolysis and oxidative phosphorylation in rat hepatocytes. Eur. J. Biochem., 263, 671-685.
51. Chien, A.J. et al. (2009) Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc. Natl Acad. Sci. USA, 106, 1193-1198.
52. Anastas, J.N. et al. (2013) WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer, 13, 11-26.
53. Kim, M.S. et al. (2010) Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma. PLoS ONE, 5, e9003.
54. Lee, S.Y. et al. (2012) Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism. Cancer Res., 72, 3607-3617.
55. Nishita, M. et al. (2010) Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization. Mol. Cell. Biol., 30, 3610-3619.
56. Sato, A. et al. (2010) Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J., 29, 41-54.
57. Takada, R. et al. (2005) Analysis of combinatorial effects of Wnts and Frizzleds on beta-catenin/armadillo stabilization and Dishevelled phosphorylation. Genes Cells, 10, 919-928.
58. Fukuda, T. et al. (2008) Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc. Natl Acad. Sci. USA, 105, 3047-3052.
59. Li, L. et al. (2009) Wnt5a induces simultaneous cortical axon outgrowth and repulsive axon guidance through distinct signaling mechanisms. J. Neurosci., 29, 5873-5883.
60. Nakajima, E.C. et al. (2013) Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol. Carcinog., 52, 329-337.